Guided Therapeutics (GTHP) Net Cash Flow (2011 - 2026)
Guided Therapeutics (GTHP) posted Net Cash Flow of -$24000.0 for Q4 2025, up 75.0% sequentially from -$96000.0 in Q3 2025, and down 112.37% YoY from $194000.0 in Q4 2024.
Guided Therapeutics (GTHP) Net Cash Flow (2011 - 2026) Analysis & Trends
Guided Therapeutics has reported Net Cash Flow for 15 years, with the latest figure at -$24000.0 in Q4 2025.
- Quarterly Net Cash Flow fell 112.37% year-over-year to -$24000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$323000.0 (down 59.11% YoY) and the FY2025 annual result came in at -$325000.0, down 60.1% from the prior year.
- Net Cash Flow climbed to -$24000.0 in Q4 2025 per GTHP's latest filing, from -$96000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $2.2 million in Q3 2022 and troughed at -$627000.0 in Q3 2023.
- A 5-year average of -$5150.0 and a median of -$143000.0 in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow soared 690.03% in 2022, then plunged 680.49% in 2023.
- Over 5 years, Net Cash Flow stood at $102000.0 in 2021, then slumped by 476.47% to -$384000.0 in 2022, then jumped by 63.54% to -$140000.0 in 2023, then jumped by 238.57% to $194000.0 in 2024, then tumbled by 112.37% to -$24000.0 in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$24000.0, -$96000.0, and $70000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -357,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -357,000.00 |
| Jun 30, 2026 | -357,000.00 |
| Mar 31, 2026 | 306,000.00 |
| Mar 31, 2026 | 306,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Sep 30, 2025 | -96,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Dec 31, 2024 | 194,000.00 |
| Sep 30, 2024 | -81,000.00 |
| Sep 30, 2024 | -81,000.00 |
| Jun 30, 2024 | -170,000.00 |
| Jun 30, 2024 | -170,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Mar 31, 2024 | -146,000.00 |